Philip Epstein is a member of the Advisory Board and Chief Executive Officer at ERI Group LLC.

Philip is an experienced public company executive and investment manager who has served as Chairman and Chief Executive Officer in the global mining, energy, renewable and pharmaceutical industries. A mergers & acquisitions and securities lawyer by training, Philip has focused on helping to found, finance, operate and monetize private and public companies since the 1990s.

Since 2015, Philip has served as CEO of ERI Group LLC (www.erigroupllc.com), a New York City based private investment and operating company focused on developing US and International projects and companies. Philip currently serves on the Board of Directors of PetroReconcavo S.A. (BVMF: RECV3) and Aviv Pharma Inc.

Previously, Philip practiced corporate finance, mergers and acquisitions and restructuring law at Fried Frank. Prior to Fried Frank, Philip practiced corporate law at Kaye Scholer where his focus was on finance and securitization.

Since 1992, Philip has played a leading role in raising and deploying approximately $1.8 Billion in capital for both public and private companies.

Philip holds a B.A. in Philosophy from the University of Chicago, an M.A. (Oxon) in Politics and Economics from Oxford University and a J.D. from Northwestern University Law School. Philip has served as a senior advisor to the International Family AIDS Program and is a past Director of the Juvenile Diabetes Research Foundation (NY Chapter).